IE
IART icon

Israel Englander’s Integra LifeSciences IART Stock Holding History

Israel Englander’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5,000
Closed -$335K – 7144
2021
Q4 		$335K Buy
+5,000
New +$338K ﹤0.01% 5427
2020
Q4 		– Sell
-10,000
Closed -$472 – 5371
2020
Q3 		$472 Buy
+10,000
New +$476K ﹤0.01% 3610
2020
Q2 		– Sell
-5,000
Closed -$223K – 4349
2020
Q1 		$223K Buy
+5,000
New +$262K ﹤0.01% 3332

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Israel Englander's IART Position: Q2 2026 in Review

Israel Englander increased its Integra LifeSciences (IART) stake by 131% in Q2 2026, buying an estimated $11.4M and bringing the position to 1,439,747 shares worth $25.9M. The position accounts for 0.01% of the portfolio, ranked #1395.

Israel Englander first reported a position in IART in Q3 2013 and has held it in 40 quarters since. The position peaked at $59.3M in Q1 2017. 211 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Israel Englander held 1,439,747 shares of Integra LifeSciences worth $25.9M as of Q2 2026.
  • Israel Englander bought 816,894 Integra LifeSciences shares in Q2 2026, an estimated $11.4M.
  • Integra LifeSciences made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1395 holding.
  • Israel Englander first reported a position in Integra LifeSciences in Q3 2013 and has held it in 40 quarters since.
  • Israel Englander's Integra LifeSciences position peaked at $59.3M in Q1 2017.
  • 211 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.